With new regulations in place, renewable energy and infrastructure investors are likely to see an increasing amount of unique and valuable investment opportunities in the Norwegian electricity sector.
The Winter Edition 2021 marks the 5-year anniversary of Haavind’s Pharma Report, our biannual report where we take a retrospective look at some of the last years legal developments relevant for the pharmaceutical sector.
The International Chamber of Commerce (ICC) new Rules of Arbitration took effect on 1 January 2021 (“the 2021 Rules”). The key modifications include changes to the expedited procedure, technology updates for electronic communications and remote hearings, new rules for joinder of additional parties to an arbitration, and disclosure of non-party funders and other rules to avoid conflict of interest. Our lawyers Mikal Brøndmo and Silje Dagsland present the main modifications below together with a link to a compared version of the 2017 and 2021 rules of arbitration.
Haavind’s Tech M&A team has acted as legal adviser to Hg in the acquisition of Geomatikk.
In the Pharma Report Summer 2020, we take a retrospective look at some of the legal developments during the first half of 2020 in the Norwegian pharmaceutical sector.